TY  - CHAP
M1  - Book, Section
TI  - Obesity
A1  - Sheehan, Amy Heck
A1  - Chen, Judy T.
A1  - Yanovski, Jack A.
A1  - Calis, Karim Anton
A2  - DiPiro, Joseph T.
A2  - Talbert, Robert L.
A2  - Yee, Gary C.
A2  - Matzke, Gary R.
A2  - Wells, Barbara G.
A2  - Posey, L. Michael
PY  - 2017
T2  - Pharmacotherapy: A Pathophysiologic Approach, 10e
AB  - Content  UpdateAugust  12,  2019Oral,  Nonsystemic  Hydrogel  Approved  for  Weight  Management  in  Adults:  In  April  2019,  the  U.S.  Food  and  Drug  Administration  (FDA)  approved  a  first-in-class  oral,  nonsystemic,  superabsorbent  hydrogel  (Plenity)  to  aid  in  weight  management  in  overweight  and  obese  adults.  The  product  is  classified  as  a  device  (not  a  drug)  and  was  shown  to  be  safe  and  effective  when  used  in  combination  with  diet  and  exercise,  resulting  in  significantly  greater  weight  loss  vs.  placebo  in  patients  with  and  without  type  2  diabetes.  The  incidence  of  adverse  events  in  the  treatment  group  was  no  different  from  placebo.  Plenity  is  the  only  prescription  product  to  be  approved  for  weight  management  in  adults  with  a  BMI  as  low  as  25  kg/m2,  and  there  is  no  restriction  on  its  duration  of  use.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/16
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1164846292
ER  -